Overview
Cyrus Khan is a Hematologist and an Oncologist practicing medicine in Pittsburgh, Pennsylvania. He has been practicing medicine for over 16 years.
Dr. Khan is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 4 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4815 Liberty Ave Ste 322, Pittsburgh, PA 15224
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Classical Hematology
Enrico M. Novelli, MD, is a classical (benign) hematologist, the Chief of the Section of Benign Hematology, and the medical director of the UPMC Adult Sickle Cell Disease Program. Board-certified in hematology, Dr. Novelli received his medical degree from the University of Milan, Italy. He completed his residency in internal medicine and fellowship in hematology-oncology at UPMC. Dr. Novelli specializes in sickle cell anemia and hemoglobinopathies. Dr. Novelli is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Novelli is board certified in American Board Of Internal Medicine. Dr. Novelli is currently accepting new patients.
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, and Nephrectomy.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
Univ. Of Pittsburgh Cancer Institute Cancer Services
Mounzer Agha is a Hematologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Agha is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Agha is currently accepting new patients.
UPMC Magee-Womens Gynecologic Oncology
Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Lymphadenectomy. Dr. Sukumvanich is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Sukumvanich is currently accepting new patients.
Frequently Asked Questions about Dr. Cyrus M. Khan
How do I make an appointment with Dr. Cyrus M. Khan?
You can book an appointment with Dr. Cyrus M. Khan by calling their office at 412-578-4484. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Cyrus M. Khan a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Cyrus M. Khan is classified as an Distinguished expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Cyrus M. Khan specialize in?
While Dr. Cyrus M. Khan is a Hematology, they have specific expertise in Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, and Non-Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Cyrus M. Khan participate in research or clinical trials?
Yes. Dr. Cyrus M. Khan has published 24 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Dr. Cyrus M. Khan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Cyrus M. Khan accept my insurance?
Dr. Cyrus M. Khan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-578-4484 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Khan isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Khan isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Khan isAdvanced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Khan isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Khan isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Follicular LymphomaDr. Khan isAdvanced. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic Lymphoma
- Multiple MyelomaDr. Khan isAdvanced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaDr. Khan isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Primary Lymphoma of the BrainDr. Khan isAdvanced. Learn about Primary Lymphoma of the Brain.
- Prolymphocytic LeukemiaDr. Khan isAdvanced. Learn about Prolymphocytic Leukemia.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Richter SyndromeDr. Khan isAdvanced. Learn about Richter Syndrome.
- Smoldering Multiple MyelomaDr. Khan isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Khan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Khan isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myelomonocytic LeukemiaDr. Khan isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Khan isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult T-Cell LeukemiaDr. Khan isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Khan isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Khan isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Antiphospholipid SyndromeDr. Khan isExperienced. Learn about Antiphospholipid Syndrome.
- Aplastic AnemiaDr. Khan isExperienced. Learn about Aplastic Anemia.
- Autoimmune Hemolytic AnemiaDr. Khan isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Burkitt LymphomaDr. Khan isExperienced. Learn about Burkitt Lymphoma.
- Cardiac AmyloidosisDr. Khan isExperienced. Learn about Cardiac Amyloidosis.
- Cerebral Amyloid AngiopathyDr. Khan isExperienced. Learn about Cerebral Amyloid Angiopathy.
- Chronic Familial NeutropeniaDr. Khan isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Myelomonocytic Leukemia (CMML)
- Chronic T-Cell Leukemia (CTCL)Dr. Khan isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Classical Hodgkin LymphomaDr. Khan isExperienced. Learn about Classical Hodgkin Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Khan isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Febrile NeutropeniaDr. Khan isExperienced. Learn about Febrile Neutropenia.
- GangliogliomaDr. Khan isExperienced. Learn about Ganglioglioma.
- Gastric LymphomaDr. Khan isExperienced. Learn about Gastric Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Khan isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hereditary Cerebral Amyloid Angiopathy
- Hodgkin LymphomaDr. Khan isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaDr. Khan isExperienced. Learn about Leukemia.
- LymphadenectomyDr. Khan isExperienced. Learn about Lymphadenectomy.
- Lymphofollicular HyperplasiaDr. Khan isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mantle Cell Lymphoma (MCL)Dr. Khan isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Dr. Khan isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myelodysplastic Syndrome (MDS)Dr. Khan isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Khan isExperienced. Learn about Myelofibrosis.
- OrchiectomyDr. Khan isExperienced. Learn about Orchiectomy.
- PlasmacytomaDr. Khan isExperienced. Learn about Plasmacytoma.
- Primary AmyloidosisDr. Khan isExperienced. Learn about Primary Amyloidosis.
- Primary Localized Cutaneous Amyloidosis
- Schnitzler SyndromeDr. Khan isExperienced. Learn about Schnitzler Syndrome.
- Small Lymphocytic Lymphoma (SLL)Dr. Khan isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- SplenomegalyDr. Khan isExperienced. Learn about Splenomegaly.
- T-Cell LymphomaDr. Khan isExperienced. Learn about T-Cell Lymphoma.
- Thrombotic Thrombocytopenic PurpuraDr. Khan isExperienced. Learn about Thrombotic Thrombocytopenic Purpura.
- Tissue BiopsyDr. Khan isExperienced. Learn about Tissue Biopsy.
- Waldenstrom MacroglobulinemiaDr. Khan isExperienced. Learn about Waldenstrom Macroglobulinemia.


